| Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline JR Brahmer, C Lacchetti, BJ Schneider, MB Atkins, KJ Brassil, ... Journal of Clinical Oncology 36 (17), 1714-1768, 2018 | 4311 | 2018 |
| Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update BJ Schneider, J Naidoo, BD Santomasso, C Lacchetti, S Adkins, ... Journal of Clinical Oncology 39 (36), 4073-4126, 2021 | 1949 | 2021 |
| Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline SH Armenian, C Lacchetti, A Barac, J Carver, LS Constine, N Denduluri, ... Journal of Clinical Oncology 35 (8), 893-911, 2017 | 1597 | 2017 |
| Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline DL Hershman, C Lacchetti, RH Dworkin, EM Lavoie Smith, J Bleeker, ... Journal of clinical oncology 32 (18), 1941-1967, 2014 | 1555 | 2014 |
| Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update CL Loprinzi, C Lacchetti, J Bleeker, G Cavaletti, C Chauhan, DL Hertz, ... Journal of Clinical Oncology 38 (28), 3325-3348, 2020 | 1067 | 2020 |
| Randomized trials stopped early for benefit: a systematic review VM Montori, PJ Devereaux, NKJ Adhikari, KEA Burns, CH Eggert, M Briel, ... Jama 294 (17), 2203-2209, 2005 | 895 | 2005 |
| Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation JE Bower, K Bak, A Berger, W Breitbart, CP Escalante, PA Ganz, ... Journal of clinical oncology 32 (17), 1840-1850, 2014 | 843 | 2014 |
| Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: ASCO clinical practice guideline focused update HJ Burstein, C Lacchetti, H Anderson, TA Buchholz, NE Davidson, ... Journal of Clinical Oncology 37 (5), 423-438, 2019 | 832 | 2019 |
| Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline JA Paice, R Portenoy, C Lacchetti, T Campbell, A Cheville, M Citron, ... Journal of Clinical Oncology 34 (27), 3325-3345, 2016 | 691 | 2016 |
| Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists JS Lewis Jr, B Beadle, JA Bishop, RD Chernock, C Colasacco, ... Archives of pathology & laboratory medicine 142 (5), 559-597, 2018 | 639 | 2018 |
| Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline PA Konstantinopoulos, B Norquist, C Lacchetti, D Armstrong, RN Grisham, ... Journal of clinical oncology 38 (11), 1222-1245, 2020 | 457 | 2020 |
| Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology clinical practice guideline adaptation of Cancer Care Ontario guideline J Carter, C Lacchetti, BL Andersen, DL Barton, S Bolte, S Damast, ... Journal of clinical oncology 36 (5), 492-511, 2018 | 433 | 2018 |
| Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: American Society of Clinical Oncology clinical practice guideline update on ovarian suppression HJ Burstein, C Lacchetti, H Anderson, TA Buchholz, NE Davidson, ... Journal of Clinical Oncology 34 (14), 1689-1701, 2016 | 431 | 2016 |
| A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals PJ Devereaux, PTL Choi, C Lacchetti, B Weaver, HJ Schünemann, ... Cmaj 166 (11), 1399-1406, 2002 | 430 | 2002 |
| Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline BD Santomasso, LJ Nastoupil, S Adkins, C Lacchetti, BJ Schneider, ... Journal of Clinical Oncology 39 (35), 3978-3992, 2021 | 392 | 2021 |
| Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials PJ Devereaux, BJ Manns, WA Ghali, H Quan, C Lacchetti, VM Montori, ... Jama 285 (15), 2000-2003, 2001 | 348 | 2001 |
| PARP inhibitors in the management of ovarian cancer: ASCO guideline WP Tew, C Lacchetti, A Ellis, K Maxian, S Banerjee, M Bookman, ... Journal of Clinical Oncology 38 (30), 3468-3493, 2020 | 343 | 2020 |
| Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis PJ Devereaux, HJ Schünemann, N Ravindran, M Bhandari, AX Garg, ... Jama 288 (19), 2449-2457, 2002 | 275 | 2002 |
| First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review J Goffin, C Lacchetti, PM Ellis, YC Ung, WK Evans Journal of Thoracic Oncology 5 (2), 260-274, 2010 | 270 | 2010 |
| Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline CL Shapiro, C Van Poznak, C Lacchetti, J Kirshner, R Eastell, R Gagel, ... Journal of Clinical Oncology 37 (31), 2916-2946, 2019 | 250 | 2019 |
